At the meeting of the American College of Cardiology held in Chicago this March, Merck & Co released some clinical data from the Phase III trials for their proposed competitor to acomplia (rimonabant). This new medication, still going by its generic name of taranabant, targets the same cannabinoid system as acomplia. It is therefore interesting to compare results since, if it gains regulatory approval, it will be a direct competitor to acomplia.
The randomised, double-blind and placebo-controlled trials recruited more than eight hundred participants who all had at least BMI 27. Merck & Co disclosed the preliminary results calculated at the end of year one of what is intended as a two year trial. In conjunction with a diet and exercise program, 28% of those taking a 2mg dose of taranabant lost more than 10% of their body weight, while 57% lost 5% of their body weight. Almost 8% of those on placebo also lost 10% of their body weight through diet and exercise alone. In terms of averages, participants taking a 2mg dose of taranabant lost 14.5 pounds compared to 5.7 pounds on placebo. Depending on how you view these things, this could be viewed as a failure because Merck & Co announced in advance that it was aiming for a minimum 5% body weight loss in all participants taking their medication.
In 2004, Acomplia’s results were that 32% on Acomplia lost more than 10% of their body weight while 62.5% lost more than 5% of their body weight. But these results were obtained at the higher dosage of 20mg as opposed to 2mg taranabant. The reason for the difference in the dosage levels is that acomplia is a CB1 receptor antagonist that blocks endogenous cannabinoid binding to neuronal CB1 receptors, while taranabant acts as a selective cannabinoid-1 receptor inverse agonist, binding to CB1 receptors. I am glad we have got that clear.
Merck & Co also tested higher doses of 4mg and 6mg but admitted problems with psychiatric side effects. It confirmed that taranabant would probably only be brought to the market at the lowest 2mg dose. Because the FDA has already expressed concern about similar side effects in acomplia, the Merck trials looked more specifically for evidence of the effects. It seems that 28% of participants on the 2mg dose reported side effects but it is not known how severe they were.
Because both medications work in a similar way, it always seemed likely that they would have similar problems with central nervous system side effects. Given that acomplia was given a rough ride by the FDA, it would seem unlikely that taranabant will fare any better on the information so far made public. Although both seem to improve the levels of high-density cholesterol and to bring down the level of triglycerides which will help to reduce the risk of heart disease, the fact that both have been associated with feelings of depression and, in some cases, suicide will probably mean that neither will be approved in the US in the near future. Even if the current trials for acomplia produce results with few or no central nervous system side effects, the results of taranabant may still drag acomplia down. If taranabant is also producing unacceptable levels of psychological disturbance at 4mg, acomplia does not look so good at higher dosages.
Nevertheless, this must be placed in a proper context. Acomplia has, of course, been available on prescription in Europe for two years and there is no emerging evidence of problems sufficiently serious to justify withdrawing approval. Indeed, it has just been given a further level of approval in the UK. If acomplia continues to accumulate a positive safety record, this may offset any prejudicial implications in the US from the taranabant trials. What should be relatively uncontroversial is that the use of the cannabinoid system for the treatment of obesity should remain firmly on the research agenda. Acomplia continues to offer an effective supplement to diet and exercise regimes. As its effects are better understood, the reported side effects may be better controlled.
Related Articles
Acomplia-Diet Pill in the Making
By: David Desousa | 24/02/2006 | Weight Loss
If you are trying to lose weight, you have plenty of company! Weight loss has become quite a mania today. Many people are seeking simple cures to the complex health problem of obesity.
Xenical in UK is a Craze amongst Obese Individuals
By: Clarence Carter | 03/08/2006 | Weight Loss
Obese individuals in UK have adopted Xenical (Orlistat) as this drug has been found to have a positive response to write off obesity. But without a balanced diet program and regular exercises the intake of Xenical alone cannot help one from getting obese.
Acomplia the High Efficacy Treatment for Obesity
By: Clarence Carter | 29/08/2006 | Medicine
Obesity is a dangerous which must be curbed. Diet pills can be helpful for an obese. Acomplia is an advanced and recently invented and highly effectively diet pill which has risen hopes of millions of obese across the globe.
Please Give Up Smoking
By: Norma D'souza | 15/11/2006 | Medicine
Do you realise why cigarette packets carry a statutory warning that ‘Smoking can cause cancer'. And still millions worldwide continue to ignore this warning sign and see their life diminish gradually in smoke.
Acomplia- a New Hope Arises
By: Hayley S | 15/02/2007 | Weight Loss
Did you wake up one morning and suddenly realize that you didn’t like the way you look? Did you realise with a shock that you had really neglected your own self? Did that make you really sad? Is it the weight increase that is the basic problem? Relax, you can find a solution once the problem has been identified.
Generic Drugs – No Monetary Problem
By: Michelle Bob | 11/07/2007 | Medicine
Happiness of a couple lives depends on their sexual life. But due to some physical deficiency, one feels himself unable to satisfy his partner. This makes their life hell since female also prefer those men who satisfy them more and more. No doubt sexual problems can cause not only physical problems but also produce a psychological problem that has immense negative impact on health.
Exercise Weight Loss and Diet Pills
By: Chris Harris | 03/01/2008 | Weight Loss
Home exercise weight loss oriented programs are a cheap alternative for hiring a personal trainer to lose weight.
Acomplia Was Riding Out to Save Me
By: Jimmy Brown | 21/04/2008 | Wellness
The article introduces the reader to a chronic smoker with a drinking problem who had a heart attack in 2006, some two months before the launch of Acomplia. He had a stent and the promise of counselling. His struggle with addiction was just beginning.
Got a Question? Ask.
Ask the community a question about this article:
Frequently Asked Questions
How/when are pills taken?
By: pnbc | 15-12-2007
how/when are pills taken?
Q&A Powered by:
Latest Nutrition Articles
All The Truth About Fat
By: Jerry Leung | 26/07/2008
Everyone talks about fat nowadays. It seems that it become the focus of most people these days. When we are still small children, our parents and teachers will tell us that fat is not good for us.
Type 2 Diabetes Can Be Better Managed With Low Glycemic Diet
By: Jackie Khor | 25/07/2008
When you eat healthy low glycemic food that does not spike your blood sugar, develop a modest, consistent exercise regime, and take high quality, complete and balanced nutritional supplements, you can significantly improve your sensitivity to your own insulin.
Special Vitamin Needs for Children
By: John Spencer Ellis | 25/07/2008
Children's bodies are growing at a rapid rate and getting the proper vitamins is vital. Here are some tips on what to consider when looking for a supplement.
Multivitamins- to Take or not to Take
By: John Spencer Ellis | 25/07/2008
One's daily health regime can be significantly enhanced by taking a multivitamin. With so many choices available, it is important to know what you should be looking for when selecting a supplement.
Fat and Water Soluble Vitamins
By: John Spencer Ellis | 25/07/2008
The difference between fat and water soluble vitamins are laid out in this article. They are both necessary for general nutrition, but knowledge of their differing functions is necessary for general knowledge of nutrition.
Real Achievers
By: Sandra Prior | 25/07/2008
As my self confidence increased, I lost my fear, and decided to change my whole life by losing weight and eating correctly. This simple decision was the best I ever made.
Instill Healthy Eating Habits in Children
By: Lyla Feldman | 25/07/2008
Toddlers are inhaling French fries, pizza, candy, and soda in record numbers because they are mimicking adults eating habits. This is counterproductive because the best time to teach dietary habits is during those early, most impressionable years. Poor diets in adults are linked to chronic conditions such as heart disease, high blood pressure, and diabetes.
Weird Eating Habits Revealed
By: Lyla Feldman | 25/07/2008
Do you have weird eating habits or do you know someone who does? What’s strange for one person might be perfectly normal for the next. For example, one of my friends is a health nut when it comes to food. That is fine, but she indulges in other things such as alcohol on a daily basis. Too much of anything is never a good thing.
More from John Scott
Fighting the Effects of the Demon Alcohol
By: John Scott | 14/06/2008 | Quit Smoking
Yet another surprising benefit in the pipeline from the use of acomplia.
What Can We Do About Pain?
By: John Scott | 24/05/2008 | Medicine
The articles notes that, in the centuries before modern science produced pain killers, people managed pain through a variety of techniques. While accepting that sometimes pain levels do demand chemical solutions, it argues that we should not be too quick to resort to pills for long-term pain management.
Warm Hands Can Make for a Healthy Heart
By: John Scott | 19/05/2008 | Sleep
The article looks at the extremes of just relying on medication as against "expensive" therapy time, and decides that biofeedback may be a middle ground for the treatment of insomnia.
Lose the Weights for Weight Loss
By: John Scott | 19/05/2008 | Weight Loss
The articles combines news from the most recent clinical trial of acomplia with advice on how best to exercise to produce optimum health outcomes.
What to Do About Neuropathic Pain?
By: John Scott | 14/05/2008 | Medicine
The article looks at the problem of neuropathic pain and how to treat it. Because the opioid drugs are generally less effective, ultram is the preferred drug because it is an atypical opioid.
Slow Release in Every Sense of the Words
By: John Scott | 08/05/2008 | Medicine
The article notes that Labopharm Inc. is closer to FDA approval for its once-daily version of ultram. It could be on the market by August 2008 which will bring the US market in line with the European markets which have had access to this format of ultram for some time.
Good News From Istanbul
By: John Scott | 08/05/2008 | Weight Loss
This article considers the results of the ADAGIO-LIPIDS study presented at Istanbul and concludes that it provides more encouraging evidence that, used wisely, acomplia is a highly effective treatment for those who are overweight and at risk of cardiovascular disease.
Instead of Counting Sheep, We Should be Counting Prescriptions
By: John Scott | 07/05/2008 | Sleep
The article wonders why insomnia seems to have become an epidemic. Millions of prescriptions a day are written around the world. Perhaps it is the 24/7 lifestyle or that we worry too much. Whatever it is, the world as a whole is suffering from lack of sleep.
Health 
